IXC 0.00% 6.6¢ invex therapeutics ltd

Ann: Phase III Clinical Trial Update and New IIH Market Analysis, page-150

  1. 795 Posts.
    lightbulb Created with Sketch. 45
    I agree. The main problem i have with this announcement is management. Alex sinclair deleting twitter and tom duthy not responding to me for a week or so which hasnt happened before is a bad sign. As well as grist getting out early, something stinks. Im still holding and am keen to clear a few things up in the next quarterly but if management remains committed i can still see this succeeding
 
watchlist Created with Sketch. Add IXC (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.